Proprietary AI analyst is now available
- Public Comps
- Research Solutions
Research Solutions Valuation Multiples
Discover Research Solutions' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Exasol, Senzime, DocCheck, Omda and more.
Research Solutions Overview
About Research Solutions
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
Founded
2006
HQ

Employees
136
Website
Sectors
Financials (LTM)
EV
$63M
Valuation Multiples
Start free trialResearch Solutions Financials
Research Solutions reported last 12-month revenue of $48M and EBITDA of $6M.
In the same LTM period, Research Solutions generated $25M in gross profit, $6M in EBITDA, and $3M in net income.
Revenue (LTM)
Research Solutions P&L
In the most recent fiscal year, Research Solutions reported revenue of $49M and EBITDA of $5M.
Research Solutions is profitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 11%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Research Solutions Stock Performance
Research Solutions has current market cap of $75M, and enterprise value of $63M.
Market Cap Evolution
Research Solutions' stock price is $2.25.
Research Solutions share price increased by 3.2% in the last 30 days, and decreased by 21.6% in the last year.
Research Solutions has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $63M | $75M | 1.6% | 3.2% | -0.4% | -21.6% | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialResearch Solutions Valuation Multiples
Research Solutions trades at 1.3x EV/Revenue multiple, and 10.7x EV/EBITDA.
EV / Revenue (LTM)
Research Solutions Financial Valuation Multiples
As of June 5, 2026, Research Solutions has market cap of $75M and EV of $63M.
Research Solutions has a P/E ratio of 26.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Research Solutions Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Research Solutions Margins & Growth Rates
Research Solutions decreased revenue by 2% but EBITDA grew by 13% in the last fiscal year.
In the most recent fiscal year, Research Solutions reported gross margin of 49%, EBITDA margin of 11%, and net margin of 3%.
Research Solutions Margins
Research Solutions Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Research Solutions Operational KPIs
Research Solutions' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Research Solutions' Rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Research Solutions' Rule of X is 13% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Research Solutions Competitors
Research Solutions competitors include Exasol, Senzime, DocCheck, Omda, Champions Oncology, Pulsar Group, JLK, BlinkLab, Forian and Health In Tech.
Most Research Solutions public comparables operate across BI & Analytics Software, Healthcare Software, Health Data & Analytics, Content Management Software, B2B SaaS and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | 1.1x | 10.1x | 11.7x | |||
| 5.9x | 5.0x | (6.2x) | (8.2x) | |||
| 0.9x | - | 4.8x | - | |||
| 2.3x | 2.3x | 8.4x | 9.1x | |||
| 1.4x | - | 10.7x | - | |||
| 1.0x | 1.0x | 5.8x | 5.3x | |||
| 28.0x | - | (8.2x) | - | |||
| - | 3866.8x | - | - | |||
This data is available for Pro users. Sign up to see all Research Solutions competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Research Solutions
Research Solutions has acquired 2 companies to date.
Last acquisition by Research Solutions was on November 27th 2023. Research Solutions acquired scite for $21M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Research Solutions
| Description | scite is a Toronto-headquartered platform analyzing over one billion citations from 150 million articles using deep learning and natural language processing. It classifies references as supporting, refuting, or mentioning claims, generating smart citations and veracity scores for papers, authors, journals, and institutions. Researchers access the tool through web and browser extensions. | ResoluteAI is an AI platform for unified information retrieval across fragmented data sources like public repositories, internal drives, and cloud storage. It employs semantic search and knowledge graphs to connect datasets for R&D teams in pharma and tech. San Francisco-headquartered, the company processes billions of documents daily, integrating with tools like Slack and Jupyter. Founded in 2022, ResoluteAI accelerates innovation by surfacing relevant patents, papers, and proprietary files in seconds. |
| HQ Country | ||
| HQ City | New York City, NY | Las Vegas, NV |
| Deal Date | 27 Nov 2023 | 31 Jul 2023 |
| Valuation | $21M | $3M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Research Solutions acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Research Solutions
| When was Research Solutions founded? | Research Solutions was founded in 2006. |
| Where is Research Solutions headquartered? | Research Solutions is headquartered in United States. |
| How many employees does Research Solutions have? | As of today, Research Solutions has over 136 employees. |
| Who is the CEO of Research Solutions? | Research Solutions' CEO is Roy W. Olivier. |
| Is Research Solutions publicly listed? | Yes, Research Solutions is a public company listed on Nasdaq. |
| What is the stock symbol of Research Solutions? | Research Solutions trades under RSSS ticker. |
| When did Research Solutions go public? | Research Solutions went public in 2009. |
| Who are competitors of Research Solutions? | Research Solutions main competitors include Exasol, Senzime, DocCheck, Omda, Champions Oncology, Pulsar Group, JLK, BlinkLab, Forian, Health In Tech. |
| What is the current market cap of Research Solutions? | Research Solutions' current market cap is $75M. |
| What is the current revenue of Research Solutions? | Research Solutions' last 12 months revenue is $48M. |
| What is the current revenue growth of Research Solutions? | Research Solutions revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Research Solutions? | Current revenue multiple of Research Solutions is 1.3x. |
| What is the current EBITDA of Research Solutions? | Research Solutions' last 12 months EBITDA is $6M. |
| What is Research Solutions' EBITDA margin? | Research Solutions' last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Research Solutions? | Current EBITDA multiple of Research Solutions is 10.7x. |
| What is the current FCF of Research Solutions? | Research Solutions' last 12 months FCF is $7M. |
| What is Research Solutions' FCF margin? | Research Solutions' last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Research Solutions? | Current FCF multiple of Research Solutions is 8.9x. |
| How many companies Research Solutions has acquired to date? | As of June 2026, Research Solutions has acquired 2 companies. |
| What was the largest acquisition by Research Solutions? | $21M acquisition of scite on 27th November 2023 was the largest M&A Research Solutions has done to date. |
| What companies Research Solutions acquired? | Research Solutions acquired scite and ResoluteAI. |
| In how many companies Research Solutions has invested to date? | Research Solutions hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Research Solutions
Lists including Research Solutions
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
